Omnicell Announces XT Amplify
Multi-year Innovation Program Designed to Maximize Value and Outcomes for XT Automated Dispensing System Omnicell , Inc. (Nasdaq:OMCL) (" Omnicell " or the "Company"), a leader in transforming the pharmacy care delivery model, today announced XT Amplify , a multi-year innovation program that is intended to maximize value for hospitals, health systems, and post-acute care facilities that ...
Omnicell launches XT Amplify - Innovative solutions designed to enhance pharmacy and nursing efficiency, reduce medication errors and waste, and ultimately maximise the value of XT Automated Dispensing System.
Omnicell Announces XT Amplify
Omnicell , Inc., a leader in transforming the pharmacy care delivery model, today announced XT Amplify , a multi-year innovation program that is intended to maximize value for hospitals, health ...
Omnicell's XT Amplify will enhance the value of existing XT technology and, in turn, ensure XT Automated Dispensing Cabinets can continually benefit from new innovations and updates. This will allow providers to adapt as the healthcare landscape evolves and their needs change.
Omnicell Announces XT Amplify
Omnicell , Inc. a leader in transforming the pharmacy care delivery model, announced XT Amplify , a multi-year innovation program that is intended to maximize value for hospitals, health systems, and post-acute care facilities that have invested in Omnicell's XT Automated Dispensing System while also seeking to drive enhanced clinical and operational outcomes at the points of care and within ...
Multi-year Innovation Program Designed to Maximize Value and Outcomes for XT Automated Dispensing System FORT WORTH, Texas-(BUSINESS WIRE)- Omnicell , Inc. (Nasdaq:OMCL) (" Omnicell " or the "Company"), a leader in transforming the pharmacy care delivery model, today announced XT Amplify , a multi-year innovation program that is intended to maximize value for hospitals, health systems ...
Omnicell, Inc. Announces XT Amplify
Omnicell , Inc. announced XT Amplify , a multi-year innovation program that is intended to maximize value for hospitals, health systems, and post-acute care facilities that have invested in Omnicell?s XT Automated Dispensing System while also seeking to drive enhanced clinical and operational outcomes at the points of care and within pharmacies.
FORT WORTH, Texas- (BUSINESS WIRE)-Omnicell, Inc. (Nasdaq:OMCL) (" Omnicell " or the "Company"), a leader in transforming the pharmacy care delivery model, today announced XT Amplify , a multi-year innovation program that is intended to maximize value for hospitals, health systems, and post-acute care facilities that have invested in Omnicell's XT Automated Dispensing System while ...
XT Amplify
Omnicell's XT Amplify is a multi-year program that maximizes the value of your existing XT Automated Dispensing System through continuous hardware, software, and services innovation—including XTExtend, MedChill, SupplyXpert, CarePlus, and ServerScale. Deliver outcomes now without waiting for new cabinets, and support your health system's journey toward the Autonomous Pharmacy.
On April 16, 2024, Omnicell , a multinational healthcare technology company, announced the launch of XT Amplify , a multi-year innovation project that aims to optimize the current pharmacy care delivery model by enhancing the existing XT Automated Dispensing Systems in their client's healthcare facilities.